FDA advisory committee recommends approval of pfizers proposed biosimilar to epogen®/procrit® across all indications

26th May 2017 Uncategorised 0

Pfizer

More: FDA advisory committee recommends approval of pfizers proposed biosimilar to epogen®/procrit® across all indications
Source: MDlinx